鼻咽癌的精确放射治疗
Precision radiotherapy for nasopharyngeal carcinoma.
作者信息
Zhang Zhenyu, Chen Xiangzhou, Yuan Taize
机构信息
Department of Radiation Oncology Guangzhou Concord Cancer Center Guangzhou Guangdong China.
出版信息
Precis Radiat Oncol. 2024 Jan 30;8(1):37-41. doi: 10.1002/pro6.1219. eCollection 2024 Mar.
Abstract
Nasopharyngeal carcinoma(NPC) occurs frequently in Southern China, and radiotherapy is the main treatment method. At present, intensity-modulated radiotherapy is widely used, which has improved efficacy in patients with NPC and reduced toxicity and side effects. Recently, helical tomography radiotherapy, proton radiotherapy, carbon particle radiotherapy, and other radiotherapy techniques have been used for the clinical treatment of NPC. Individualized nasopharyngeal cancer targets have also been explored. This paper reviews the research progress in radiotherapy techniques and target volume for NPC.
摘要
鼻咽癌（NPC）在中国南方地区高发，放射治疗是主要的治疗方法。目前，调强放射治疗被广泛应用，其提高了鼻咽癌患者的疗效，降低了毒性和副作用。近年来，螺旋断层放射治疗、质子放射治疗、碳粒子放射治疗等放射治疗技术已用于鼻咽癌的临床治疗。个体化鼻咽癌靶区也得到了探索。本文综述了鼻咽癌放射治疗技术和靶区体积的研究进展。
相似文献
1
Precision radiotherapy for nasopharyngeal carcinoma.
Precis Radiat Oncol. 2024 Jan 30;8(1):37-41. doi: 10.1002/pro6.1219. eCollection 2024 Mar.
2
Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
Chin J Cancer. 2016 Dec 22;35(1):101. doi: 10.1186/s40880-016-0164-5.
3
Phase I/II Trial Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma.
J Cancer. 2016 Apr 10;7(7):774-83. doi: 10.7150/jca.14399. eCollection 2016.
4
Radiomics for Diagnosis and Radiotherapy of Nasopharyngeal Carcinoma.
Front Oncol. 2022 Jan 5;11:767134. doi: 10.3389/fonc.2021.767134. eCollection 2021.
5
The efficacy and toxicity of individualized intensity-modulated radiotherapy based on the tumor extension patterns of nasopharyngeal carcinoma.
Oncotarget. 2016 Apr 12;7(15):20680-90. doi: 10.18632/oncotarget.8004.
6
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.
JAMA Netw Open. 2021 Jun 1;4(6):e2113205. doi: 10.1001/jamanetworkopen.2021.13205.
7
MiRNAs in Radiotherapy Resistance of Nasopharyngeal Carcinoma.
J Cancer. 2020 Apr 6;11(13):3976-3985. doi: 10.7150/jca.42734. eCollection 2020.
8
Clinical outcome of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy in locally advanced nasopharyngeal carcinoma: Comparative study at SKIMS Tertiary Care Institute.
J Cancer Res Ther. 2022 Jan-Mar;18(1):133-139. doi: 10.4103/jcrt.jcrt_169_21.
9
Long-term Outcomes Following Individualized Primary Tumor Clinical Target Volume Delineation Based on Stepwise Spread Patterns of Nasopharyngeal Carcinoma Treated With Intensity-Modulated Radiotherapy.
Int J Radiat Oncol Biol Phys. 2025 May 1;122(1):126-139. doi: 10.1016/j.ijrobp.2024.12.006. Epub 2024 Dec 17.
10
Impact of changes in psychological resilience during treatment with intensity-modulated radiotherapy on nasopharyngeal carcinoma patients: a prospective study.
Ann Palliat Med. 2022 Jan;11(1):123-134. doi: 10.21037/apm-21-3592.
引用本文的文献
1
LASSO-Cox model in the prognostic evaluation of radiochemotherapy efficacy for lymph node metastatic nasopharyngeal carcinoma.
Front Oncol. 2025 Jun 4;15:1606967. doi: 10.3389/fonc.2025.1606967. eCollection 2025.
2
Machine Learning Radiomics for Predicting Response to MR-Guided Radiotherapy in Unresectable Hepatocellular Carcinoma: A Multicenter Cohort Study.
J Hepatocell Carcinoma. 2025 May 9;12:933-947. doi: 10.2147/JHC.S521378. eCollection 2025.
本文引用的文献
1
Medial retropharyngeal nodal region sparing radiotherapy versus standard radiotherapy in patients with nasopharyngeal carcinoma: open label, non-inferiority, multicentre, randomised, phase 3 trial.
BMJ. 2023 Feb 6;380:e072133. doi: 10.1136/bmj-2022-072133.
2
Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial.
Lancet Oncol. 2022 Apr;23(4):479-490. doi: 10.1016/S1470-2045(22)00058-4. Epub 2022 Feb 28.
3
Dosimetric Comparison of Helical Tomotherapy, Volume-Modulated Arc Therapy, and Fixed-Field Intensity-Modulated Radiation Therapy in Locally Advanced Nasopharyngeal Carcinoma.
Front Oncol. 2021 Nov 5;11:764946. doi: 10.3389/fonc.2021.764946. eCollection 2021.
4
Mixed Photon and Carbon-Ion Beam Radiotherapy in the Management of Non-Metastatic Nasopharyngeal Carcinoma.
Front Oncol. 2021 Jul 23;11:653050. doi: 10.3389/fonc.2021.653050. eCollection 2021.
5
A Systematic Review of Proton Therapy for the Management of Nasopharyngeal Cancer.
Int J Part Ther. 2021 Jun 25;8(1):119-130. doi: 10.14338/IJPT-20-00082.1. eCollection 2021 Summer.
6
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.
JAMA Netw Open. 2021 Jun 1;4(6):e2113205. doi: 10.1001/jamanetworkopen.2021.13205.
7
Clinical value of docetaxel plus cisplatin (TP) induction chemotherapy followed by TP concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma.
J Cancer. 2021 Jan 1;12(1):18-27. doi: 10.7150/jca.49944. eCollection 2021.
8
Clinical outcomes of carbon-ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma.
Cancer. 2020 Dec 1;126(23):5173-5183. doi: 10.1002/cncr.33197. Epub 2020 Sep 15.
9
Toxicity and dosimetric analysis of nasopharyngeal carcinoma patients undergoing radiotherapy with IMRT or VMAT: A regional center's experience.
Oral Oncol. 2020 Aug 27;109:104978. doi: 10.1016/j.oraloncology.2020.104978.
10
Proton pencil-beam scanning radiotherapy in the treatment of nasopharyngeal cancer: dosimetric parameters and 2-year results.
Eur Arch Otorhinolaryngol. 2021 Mar;278(3):763-769. doi: 10.1007/s00405-020-06175-5. Epub 2020 Jul 4.
Zotero 插件